Association Analysis of the Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) and Autoimmune Regulator-1 (AIRE-1) Genes in Sporadic Autoimmune Addison's Disease
Overview
Authors
Affiliations
Although autoimmune Addison's disease (AAD) may occur as a component of the monogenic autoimmune polyendocrinopathy type 1 syndrome (APS1), it is most commonly found as an isolated disorder or associated with the autoimmune polyendocrinopathy type 2 syndrome (APS2). It is likely that sporadic (non-APS1) AAD is inherited as a complex trait; however, apart from the major histocompatibility complex, the susceptibility genes remain unknown. We have examined polymorphisms at two non-major histocompatibility complex candidate susceptibility loci in sporadic (non-APS1) AAD: the cytotoxic T lymphocyte antigen-4 (CTLA-4) gene and the autoimmune regulator (AIRE-1) gene. DNA samples from AAD subjects (n = 90) and local controls (n = 144 for CTLA-4; n = 576 for AIRE-1) were analyzed for the CTLA-4A/G polymorphism in exon 1 of the CTLA-4 gene and for the common mutant AIRE-1 allele (964de113) in United Kingdom subjects with APS1, by using the restriction enzymes Bst7II and BsrBI, respectively. There was an association of the G allele at CTLA-4A/G in AAD subjects (P = 0.008 vs. controls), which was stronger in subjects with AAD as a component of APS2 than in subjects with isolated AAD. In contrast, the mutant AIRE-1 964del13 allele was carried in one each of the 576 (0.2%) control subjects and the 90 (1.1%) AAD subjects as a heterozygote (P = 0.254, not significant), suggesting that this common AIRE-1 gene abnormality does not have a major role in sporadic (non-APS1) AAD.
Insilico prediction and functional analysis of nonsynonymous SNPs in human CTLA4 gene.
Irfan M, Iqbal T, Hashmi S, Ghani U, Bhatti A Sci Rep. 2022; 12(1):20441.
PMID: 36443461 PMC: 9705290. DOI: 10.1038/s41598-022-24699-0.
Fierabracci A, Belcastro E, Carbone E, Pagliarosi O, Palma A, Pacillo L J Clin Med. 2022; 11(11).
PMID: 35683627 PMC: 9181695. DOI: 10.3390/jcm11113242.
The genetics of autoimmune Addison disease: past, present and future.
Royrvik E, Husebye E Nat Rev Endocrinol. 2022; 18(7):399-412.
PMID: 35411072 DOI: 10.1038/s41574-022-00653-y.
Calvete O, Reyes J, Valdes-Socin H, Martin P, Marazuela M, Barroso A Cells. 2021; 10(12).
PMID: 34944008 PMC: 8700745. DOI: 10.3390/cells10123500.
Eriksson D, Royrvik E, Aranda-Guillen M, Berger A, Landegren N, Artaza H Nat Commun. 2021; 12(1):959.
PMID: 33574239 PMC: 7878795. DOI: 10.1038/s41467-021-21015-8.